In vitro inhibition of the measles virus by novel ring-expanded ('fat') nucleoside analogues containing the imidazo[4,5-e][1,3]diazepine ring system

Bioorganic and Medicinal Chemistry Letters

Volumn 12, Issue 23, 2002, Pages 3391-3394

  Zhang, Ning ^a   Chen, Huan Ming ^a   Sood, Ramesh ^b   Kalicharran, Kishna ^b   Fattom, Ali I ^b   Naso, Robert B ^b   Barnard, Dale L ^c   Sidwell, Robert W ^c   Hosmane, Ramachandra S ^a  

^a UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^b Nabi   (United States)

^c UTAH STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPINE DERIVATIVE; ESTER DERIVATIVE; HETEROCYCLIC COMPOUND; NUCLEOSIDE DERIVATIVE; RIBAVIRIN; ANTIVIRUS AGENT; AZEPINE DERIVATIVE; GUANIDINE; IMIDAZOLE DERIVATIVE; NUCLEOSIDE;

ANTIVIRAL ACTIVITY; ARTICLE; CATALYSIS; CELL STRAIN COS7; CYTOPATHOGENIC EFFECT; DRUG CYTOTOXICITY; DRUG SCREENING; DRUG SYNTHESIS; HYDROPHOBICITY; IN VITRO STUDY; MEASLES; MEASLES VIRUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POLYMERIZATION; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION; TOXICITY TESTING; VIRUS INHIBITION; ANIMAL; CELL LINE; CERCOPITHECUS; CHEMISTRY; CYTOLOGY; DRUG EFFECT; IC 50; KIDNEY;

CERCOPITHECUS AETHIOPS; MEASLES VIRUS;

ANIMALS; ANTIVIRAL AGENTS; AZEPINES; CELL LINE; CERCOPITHECUS AETHIOPS; GUANIDINE; HYDROPHOBICITY; IMIDAZOLES; INHIBITORY CONCENTRATION 50; KIDNEY; MEASLES VIRUS; NUCLEOSIDES;

EID: 0036888775     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00762-X     Document Type: Article

References (13)

1. Naniche D., Yeh A., Eto D., Manchester M., Friedman R.M., Oldstone M.B. J. Virol. 74:2000;7478.
2. Chien J.W., Johnson J.L. Postgrad. Med. 107:2000;67.
3. Schneider-Schaulies J., Niewiesk S., Schneider-Schaulies S., ter Meulen V. J. Neurovirol. 5:1999;613.
4. Horikami S.M., Moyer S.A. Curr. Topics Microbiol. Immunol. 191:1995;35.
5. Chen H.-M., Sood R., Hosmane R.S. Nucleosides Nucleotides. 18:1999;331.
6. Anderson W.K., Bhattacharjee D., Houston D.M. J. Med. Chem. 32:1989;119.
7. Snyder H.R., Hendrick R.G., Broks L.A. Org. Synth. 22:1947;65.
8. Moriya O., Minamide H., Urata Y. Synthesis. 12:1984;1057.
9. Sheppard W.A., Webster O.W. J. Am. Chem. Soc. 95:1973;2695.
10. 4 and filtering, the chloroform solution was evaporated to dryness in vacuo to obtain the product 6 either as a foam or solid, which was recrystallized from the appropriate solvent or purified by silica gel flash chromatography to give the pure product 6. The solvent of recrystallization and/or eluting solvent for column or prep-TLC chromatography, along with physical, spectral, and analytical data for 6 are given below:
11. Barnard D.L., Hill C.L., Gage T., Matheson J.E., Huffman J.H., Sidwell R.W., Otto M.I., Schinazi R.F. Antiviral Res. 34:1997;27.
12. Smith R.K., Kirkpatrick W. Ribavirin - A Broad Spectrum Antiviral Agent. 1980;Academic, New York.
13. Baxter, R. A.; Spring, F. S. J. Chem. Soc. (London) 1945, 232.